
    
      Intervention: Subjects were randomly assigned to receive control treatment (intravenous
      fluid, oral rice and half strength milk formula) or add-on treatment of the probiotics
      (Bio-three®) to the control treatment.

      Main outcome measures: Quantitative Vesikari scales and qualitative severe diarrhea (Vesikari
      scale≥11) Exclusion criteria included immunodeficiency, severe abdominal distension with risk
      of bowel perforation, severe infection or sepsis, history of gastrointestinal tract surgery,
      and probiotics use in the preceding 1 week.
    
  